Earth Pharmaceutical announces the dissolution of its exclusive distribution and sales agreement with Haleon Japan in Japan by December 31, 2026. After the contract ends, operations will be returned to Haleon, with only a minor impact expected on this year’s consolidated results.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4985","jir_company_name":"Earth Pharmaceutical Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-07-01","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/07\/4985-20260701-01.pdf","jir_short_summary":"Earth Pharmaceutical announces the dissolution of its exclusive distribution and sales agreement with Haleon Japan in Japan by December 31, 2026. After the contract ends, operations will be returned to Haleon, with only a minor impact expected on this year's consolidated results.","jir_summary":"### Overview of the contract dissolution\nThis notice explains the decision to terminate the exclusive distribution and sales agency contract for denture-related and toothpaste-related products in the Japanese market that has been in place since 1996 with Haleon Japan Co., Ltd., with the aim of further developing both companies. The dissolution date is December 31, 2026, and it is stated that operations will be returned to Haleon thereafter.\n\n### Financial impact and outlook\nThe impact of contract dissolution on this year's consolidated results is expected to be minor. Specific effects on sales or costs have not been disclosed. Inquiries are directed to the Corporate Planning Headquarters, with Haleon Japan listed as the product-specific contact.","jir_financial_highlights":"This year's consolidated financial impact: Unknown (Unknown)","jir_category":"","jir_hashtags":"#EarthPharmaceutical, #Haleon, #IR, #JapanStocks","jir_key_figures":"Dissolution date: December 31, 2026\nImpact: Minor (undetermined)\nInquiries: Earth Pharmaceutical Co., Ltd. Corporate Planning Headquarters, Haleon Japan Co., Ltd.","jir_meta_title":"Earth Pharmaceutical: Notice of Exclusive Contract Dissolution | End of December 2026","jir_meta_description":"Earth Pharmaceutical will dissolve its exclusive distribution and sales contract with Haleon Japan by December 31, 2026. The impact on this year's results is expected to be minor, with forthcoming actions explained.","jir_og_title":"Earth Pharmaceutical: Notice of Exclusive Contract Dissolution | End of December 2026","jir_og_description":"Earth Pharmaceutical dissolves its exclusive distribution contract with Haleon Japan. The dissolution date is December 31, 2026, with minor anticipated impact.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":9486,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"general_ir","footnotes":""},"sector":[],"importance":[],"class_list":["post-74460","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n